ArticleScientific reports2016

Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus.

Ryohei Saga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.